Daiichi Sankyo
$70.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$70.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.46 (+3.62%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours
Why Robinhood?
You can buy or sell Daiichi Sankyo and other stocks, options, ETFs, and crypto commission-free!
About DSNKY
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. Read More The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan. DSNKY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
CEO
Employees
14,887
Headquarters
Tokyo, Tokyo
Founded
2005
Market Cap
42.01B
Price-Earnings Ratio
33.33
Dividend Yield
—
Average Volume
24.86K
High Today
$71.44
Low Today
$68.55
Open Price
$68.55
Volume
19.40K
52 Week High
$74.97
52 Week Low
$40.04